← Back to Patent Explorer
US5004810A Expired / Lapsed US ⏱️ 0.0 years remaining

Antiviral oligomers

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1988-09-30
•
Granted: 1991-04-02
•
Expires: 2008-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Oligomers that are complementary in base sequence to the initiation region on mRNA coding for herpes simplex virus transactivating proteins inhibit the replication of the virus.

Inventors

  • 👤 Kenneth G. Draper

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 18:48
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; C; C07; C07H; C07H21/00; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; C12N15/1131; C12N15/1133

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 65 words
An oligomer capable of hybridizing to the second translation initiation region downstream from the 5' end of messenger RNA coding for a herpes simplex virus Vmw65 transactivating protein and substantially inhibiting translation of such messenger RNA, which oligomer comprises bases substantially complementary to such translation initiation region linked by a backbone comprising ribose phosphate, deoxyribose phosphate, ribose alkylphosphonate, deoxyribose alkylphosphonate, ribose arylphosphonate or deoxyribose arylphosphonate.
Claim 2
Dependent Claim 65 words
An oligomer capable of hybridizing to the second translation initiation region downstream from the 5' end of messenger RNA coding for a herpes simplex virus Vmw65 transactivating protein and substantially inhibiting translation of such messenger RNA, which oligomer comprises bases substantially complementary to such translation initiation region linked by a backbone comprising ribose phosphate, deoxyribose phosphate, ribose alkylphosphonate, deoxyribose alkylphosphonate, ribose arylphosphonate or deoxyribose arylphosphonate.
Claim 3
Dependent Claim 15 words
The oligomer of claim 1 in which the backbone comprises deoxyribose phosphate or deoxyribose alkylphosphonate.
Claim 4
Dependent Claim 22 words
The oligomer of claim 1 which is an oligodeoxynucleotide having the sequence, from 5' to 3': GTC CGC GTC CAT GTC GGC.

References Cited (Backward Citations)

US4757055A Cited
WO1983001451A1 Cited
GB2148302A Cited
US4689320A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-04-01 1994-10-01 1995-04-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-04-01 1998-10-01 1999-04-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-04-01 2002-10-01 2003-04-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag